Cost effectiveness of transcatheter aortic valve replacement compared to medical management in inoperable patients with severe aortic stenosis: Canadian analysis based on the PARTNER Trial Cohort B findings

JOURNAL ARTICLE published April 2013 in Journal of Medical Economics

Authors: Rebecca L. Hancock-Howard | Christopher M. Feindel | Josep Rodes-Cabau | John G. Webb | Ann K. Thompson | Kurt Banz

Cost-effectiveness of rivaroxaban compared with enoxaparin plus a vitamin K antagonist for the treatment of venous thromboembolism

JOURNAL ARTICLE published January 2014 in Journal of Medical Economics

Authors: Patrick Lefebvre | Craig I. Coleman | Brahim K. Bookhart | Si-Tien Wang | Samir H. Mody | Kevin N. Tran | Daisy Y. Zhuo | Lynn Huynh | Edith A. Nutescu

Healthcare utilization of back pain patients: results of a claims data analysis

JOURNAL ARTICLE published January 2011 in Journal of Medical Economics

Authors: G. Müller-Schwefe | A. Freytag | A. Höer | G. Schiffhorst | A. Becker | H.-R. Casser | G. Glaeske | R. Thoma | R.-D. Treede

Identifying chronic disease patients using predictive algorithms in pharmacy administrative claims: an application in rheumatoid arthritis

JOURNAL ARTICLE published 1 January 2021 in Journal of Medical Economics

Authors: Ervant J. Maksabedian Hernandez | Isabelle Tingzon | Lorenzo Ampil | Jessica Tiu

Biomarkers and pharmacoeconomics in rheumatoid arthritis: a good marriage

JOURNAL ARTICLE published 1 September 2020 in Journal of Medical Economics

Authors: Maurizio Benucci | Maria Infantino | Mariangela Manfredi

The economic advantages of response in the treatment of advanced breast cancer

JOURNAL ARTICLE published January 1999 in Journal of Medical Economics

Authors: Ruth E Brown | Anita Burrell

A budget impact analysis for making treatment decisions based on anti-cyclic citrullinated peptide (anti-CCP) testing in rheumatoid arthritis

JOURNAL ARTICLE published 2 June 2020 in Journal of Medical Economics

Authors: Sang Hee Park | Xue Han | Francis Lobo | David Kratochvil | Dipen Patel

Costs of hospital events in patients with metastatic colorectal cancer

JOURNAL ARTICLE published January 2011 in Journal of Medical Economics

Authors: Jetty A. Overbeek | Zhongyun Zhao | Myrthe P. P. van Herk-Sukel | Beth L. Barber | Sue Gao | Ron M. C. Herings

Cost-effectiveness of glatiramer acetate and interferon beta-1a for relapsing-remitting multiple sclerosis, based on the CombiRx study

JOURNAL ARTICLE published March 2014 in Journal of Medical Economics

Authors: Josep Darbà | Lisette Kaskens | Rainel Sánchez-de la Rosa

Evaluating the relationship between daily self-monitoring of blood glucose and healthcare costs

JOURNAL ARTICLE published January 2007 in Journal of Medical Economics

Authors: Mei-Jen Ho | Vijay N Joish | George L White | Stephen C Alder | Gary M Oderda

Healthcare utilization and costs of veterans health administration patients with schizophrenia treated with paliperidone palmitate long-acting injection or oral atypical antipsychotics

JOURNAL ARTICLE published 4 May 2015 in Journal of Medical Economics

Authors: Onur Baser | Lin Xie | Jacqueline Pesa | Mike Durkin

A comparison of preferences for two GLP-1 products – liraglutide and exenatide – for the treatment of type 2 diabetes

JOURNAL ARTICLE published December 2010 in Journal of Medical Economics

Authors: Michael Polster | Elaine Zanutto | Susan McDonald | Christopher Conner | Mette Hammer

Duloxetine compliance and its association with healthcare costs among patients with diabetic peripheral neuropathic pain

JOURNAL ARTICLE published January 2009 in Journal of Medical Economics

Authors: N. Wu | S. Chen | L. Boulanger | K. Fraser | S. L. Bledsoe | Y. Zhao

Cost-effectiveness of axicabtagene ciloleucel for adult patients with relapsed or refractory large B-cell lymphoma in the United States

JOURNAL ARTICLE published 2 December 2018 in Journal of Medical Economics

Authors: Joshua A. Roth | Sean D. Sullivan | Vincent W. Lin | Aasthaa Bansal | Anna G. Purdum | Lynn Navale | Paul Cheng | Scott D. Ramsey

Changes in mortality associated with cancer drug approvals in the United States from 2000 to 2016

JOURNAL ARTICLE published 1 December 2020 in Journal of Medical Economics

Authors: Joanna P. MacEwan | Syvart Dennen | Rebecca Kee | Farzad Ali | Jason Shafrin | Katharine Batt

The economic burden of systemic lupus erythematosus in Mexico

JOURNAL ARTICLE published 6 March 2024 in Journal of Medical Economics

Authors: Gihan Hamdy Elsisi | Lilia Andrade-Ortega | Margarita Portela | Gabriel Medrano Ramírez | Daniel Xavier Xibillé Friedmann

The economic burden of systemic lupus erythematosus in Taiwan

JOURNAL ARTICLE published 6 March 2024 in Journal of Medical Economics

Authors: Gihan Hamdy Elsisi | Song-Chou Hsieh | Der-Yuan Chen

Addendum

JOURNAL ARTICLE published 31 December 2024 in Journal of Medical Economics

Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis

JOURNAL ARTICLE published 2 June 2020 in Journal of Medical Economics

Authors: B. B. Hansen | S. Nuhoho | S. N. Ali | T. Dang-Tan | W. J. Valentine | S. J. P. Malkin | B. Hunt

An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England

JOURNAL ARTICLE published 1 January 2021 in Journal of Medical Economics

Authors: Christopher Raspin | Rohit Shankar | Francesca Barion | Vicki Pollit | Joanna Murphy | Laura Sawyer | Vanessa Danielson